Transgene SA
TRGNF
$0.70
-$0.89-55.98%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -9.32M | -9.61M | -8.87M | -8.95M | -3.46M |
| Total Depreciation and Amortization | 359.20K | 370.50K | 326.70K | 329.50K | 415.60K |
| Total Amortization of Deferred Charges | 736.10K | 759.10K | -- | -- | 4.36M |
| Total Other Non-Cash Items | -1.71M | -1.76M | 112.50K | 113.40K | -8.85M |
| Change in Net Operating Assets | 7.26M | 7.49M | -1.54M | -1.56M | -1.62M |
| Cash from Operations | -2.67M | -2.76M | -9.97M | -10.06M | -9.16M |
| Capital Expenditure | -566.00K | -583.80K | -1.08M | -1.09M | -680.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -372.00K | -383.70K | 300.30K | 302.90K | 9.66M |
| Cash from Investing | -938.10K | -967.50K | -778.20K | -784.90K | 8.97M |
| Total Debt Issued | -10.00M | -10.00M | 10.00M | 10.00M | -- |
| Total Debt Repaid | -36.50K | -36.50K | -583.50K | -583.50K | -291.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 13.90M | 13.90M | 200.50K | 200.50K | 6.43M |
| Cash from Financing | 4.12M | 4.25M | 10.35M | 10.44M | 6.61M |
| Foreign Exchange rate Adjustments | 212.70K | 219.30K | 215.30K | 217.10K | 0.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 719.50K | 742.10K | -186.20K | -187.80K | 6.43M |